AOD-9604 (Anti-Obesity Drug 9604) is a modified peptide fragment consisting of the terminal 15 amino acids of human growth hormone (positions 176-191) with a tyrosine residue added at the N-terminus for stability
Matrixyl 3000 has minimal documented antioxidant activity by comparison
Praesent dictum augue sit amet neque faucibus, ac varius enim convallis
Zhou M, Wu X, Luo J, Yang G, Lu Y, Lin S, et al
Key Research Areas Gastrointestinal mucosal protection BPC-157 is studied in gut tissue models for its interaction with gastric mucosal repair pathways, including protection against NSAID-induced lesions and inflammatory bowel disease models Tendon and ligament biology Investigated in in-vitro and rodent models for its influence on fibroblast activity, collagen synthesis, and tendon-to-bone attachment repair Angiogenesis Studied for its promotion of VEGF expression and new blood vessel formation in wound healing and ischaemia models Neuroprotection Referenced in studies examining dopamine and serotonin system modulation
It also stimulates collagen production